Goldbach, Pierre,Mahler, Hanns-Christian,Mueller, Robert
申请号：
HRP20160434
公开号：
HRP20160434T1
申请日:
2016.04.21
申请国别(地区):
HR
年份:
2016
代理人:
摘要：
The present invention relates to a pharmaceutical formulation comprising about 50 mg/ml-200 mg/ml of an Abeta antibody, about 0.01%-0.1% poloxamer, about 5 mM-50 mM of a buffer, about 100 mM-300 mM of a stabilizer at a pH of about 4.5-7.0.
